Experimental reduction of NLRP1 or caspase1 expression in APP/PS1 (an AD model) mice attenuated the Aβ deposition, reduced neuronal pyroptosis, and improved cognitive deficits (Tan et al., 2014; Flores et al., 2022). Here, APP is linked to Alzheimer disease.